In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...

A new study from the University of Toronto is changing how scientists think about early signs of dementia. While memory loss ...

As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...

The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.

A new study has explored a potential link between a particular sleep pattern and the risk of Alzheimer’s disease ...

A tiny flower-shaped particle could help to pave the way for a new treatment approach to Alzheimer's and Parkinson's that targets the root causes.

Okanagan Clinical Trials is offering new opportunities for people to participate in important clinical research studies ...

The AFA opens a new Alzheimer’s support center in Amityville, offering programs, memory screenings and caregiver respite for ...

Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...

Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...

Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...